A global study involving McMaster University researchers has trialled a potential new treatment that could be a game-changer for people living with hemophilia A, a life-threatening genetic blood disorder.
CAHS fellows are elected by their peers in recognition of excellence in academic health sciences and their lifelong commitment to their fields.